Keith E. Donovan

2/13/2026 12:59:37 PM

What Dupixent Users Should Know in 2026: A Patient Advocacy Guide

By Keith E. Donovan Matthew R. Fogg

If you or someone you love uses Dupixent, you may have recently seen television ads or online headlines linking the medication to rare...

12/23/2025 3:38:37 PM

By Keith E. Donovan Matthew R. Fogg

When we take prescription medications, we trust that they will help us feel better, not leave us with devastating side effects we were...

12/17/2025 12:39:38 PM

By Keith E. Donovan Matthew R. Fogg

The U.S. Food and Drug Administration (FDA) has approved a significant update to the prescribing information for Depo-Provera, adding a...

12/8/2025 9:43:37 PM

By Keith E. Donovan

Morris James' Managing Partner, Keith Donovan, has been named a Delaware 222 Honoree by Delaware Business Times for his contributions to...

12/8/2025 7:27:38 PM

By Keith E. Donovan Matthew R. Fogg

A diagnosis of T-cell lymphoma after using Dupixent raises serious questions for patients and families. Many want clear answers about...

10/30/2025 5:44:37 PM

By Keith E. Donovan Matthew R. Fogg

When you start a medication like Dupixent (dupilumab), you expect relief from eczema or asthma, not the devastation of a cancer...

10/30/2025 1:42:02 PM

By Keith E. Donovan Matthew R. Fogg

The first known lawsuit has now been filed against the makers of Dupixent (dupilumab), alleging that the popular eczema and asthma drug...

10/6/2025 11:39:37 PM

By Keith E. Donovan Matthew R. Fogg

As more patients come forward with questions about the potential link between dupilumab (Dupixent®) and certain types of cancer, it’s...